Please login to the form below

Not currently logged in
Email:
Password:

Sir Tom Blundell to remain as chair of UK’s biotech research council

Reappointed to government role to support research

BBSRC Sir Tom BlundellSir Tom Blundell has been reappointed as chair of the UK's Biotechnology and Biological Sciences Research Council (BBSRC), a government-funded organisation to support research in the UK.

This is Sir Tom's second term in the position, having originally been appointed to the role in July 2009. He will now serve a further two years more than his original four-year term, with his reappointment lasting until June 30, 2015.

He was also one of the initial founders of the BBSRC in 1994, serving for two years as its chief executive.

“I am delighted that Sir Tom Blundell has agreed to remain as chair of BBSRC,” said David Willetts, minister for universities and science.

“His extensive academic experience in the field of biochemistry coupled with his active role in science policy makes him an invaluable asset to the council.”

This experience includes Sir Tom's current role as professor emeritus and director of research in biochemistry at the University of Cambridge. 

He was previously head of the School of Biological Sciences in Cambridge and Sir William Dunn Professor of Biochemistry.

Sir Tom has prior experience in science policy, serving as a member of the advisory group to the Prime Minister in the 1980s.

He has also spent time as chairman of the Royal Commission on Environmental Pollution, president of the UK Biosciences Federation and president of UK Science Council.

In addition to his academic and policy background, Sir Tom has industry experience, serving as non-executive director of biotech Celltech from 1996 to 2005 and holding advisory roles with Pfizer, UCB and SmithKline Beecham (now part of GSK).

27th February 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics